Severe COVID-19 Infection and Pediatric Comorbidities: A Systematic Review and Meta-Analysis
Objective: There is limited information on the severity of COVID-19 infection in children with comorbidities. We investigated the effects of pediatric comorbidities on COVID-19 severity by means of a systematic review and meta-analysis of published literature. Methods: PubMed, Embase, and Medline databases were searched for publications on pediatric COVID-19 infections published January 1st to October 5th, 2020. Articles describing at least one child with and without comorbidities, COVID-19 infection, and reported outcomes were included. Results: 42 studies containing 275,661 children without comorbidities and 9,353 children with comorbidities were included. Severe COVID-19 was present in 5.1% of children with comorbidities, and in 0.2% without comorbidities. Random-effects analysis revealed a higher risk of severe COVID-19 among children with comorbidities than for healthy children; relative risk ratio 1.79 (95% CI 1.27 – 2.51; I2 = 94%). Children with underlying conditions also had a higher risk of COVID-19-associated mortality; relative risk ratio 2.81 (95% CI 1.31 – 6.02; I2 = 82%). Children with obesity had a relative risk ratio of 2.87 (95% CI 1.16 – 7.07; I2 = 36%). Conclusions: Children with comorbidities have a higher risk of severe COVID-19 and associated mortality than children without underlying disease. Additional studies are required to further evaluate this relationship..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:103 |
---|---|
Enthalten in: |
International Journal of Infectious Diseases - 103(2021), Seite 246-256 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Boyan K. Tsankov [VerfasserIn] |
---|
Links: |
doi.org [kostenfrei] |
---|
Themen: |
COVID-19 |
---|
doi: |
10.1016/j.ijid.2020.11.163 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
DOAJ056256671 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ056256671 | ||
003 | DE-627 | ||
005 | 20230308200228.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230227s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.ijid.2020.11.163 |2 doi | |
035 | |a (DE-627)DOAJ056256671 | ||
035 | |a (DE-599)DOAJ4289576de7fd4bee8656a08dae821277 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
050 | 0 | |a RC109-216 | |
100 | 0 | |a Boyan K. Tsankov |e verfasserin |4 aut | |
245 | 1 | 0 | |a Severe COVID-19 Infection and Pediatric Comorbidities: A Systematic Review and Meta-Analysis |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Objective: There is limited information on the severity of COVID-19 infection in children with comorbidities. We investigated the effects of pediatric comorbidities on COVID-19 severity by means of a systematic review and meta-analysis of published literature. Methods: PubMed, Embase, and Medline databases were searched for publications on pediatric COVID-19 infections published January 1st to October 5th, 2020. Articles describing at least one child with and without comorbidities, COVID-19 infection, and reported outcomes were included. Results: 42 studies containing 275,661 children without comorbidities and 9,353 children with comorbidities were included. Severe COVID-19 was present in 5.1% of children with comorbidities, and in 0.2% without comorbidities. Random-effects analysis revealed a higher risk of severe COVID-19 among children with comorbidities than for healthy children; relative risk ratio 1.79 (95% CI 1.27 – 2.51; I2 = 94%). Children with underlying conditions also had a higher risk of COVID-19-associated mortality; relative risk ratio 2.81 (95% CI 1.31 – 6.02; I2 = 82%). Children with obesity had a relative risk ratio of 2.87 (95% CI 1.16 – 7.07; I2 = 36%). Conclusions: Children with comorbidities have a higher risk of severe COVID-19 and associated mortality than children without underlying disease. Additional studies are required to further evaluate this relationship. | ||
650 | 4 | |a Coronavirus | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a Pediatrics | |
650 | 4 | |a Comorbidity | |
650 | 4 | |a Meta-Analysis | |
653 | 0 | |a Infectious and parasitic diseases | |
700 | 0 | |a Joannie M. Allaire |e verfasserin |4 aut | |
700 | 0 | |a Michael A. Irvine |e verfasserin |4 aut | |
700 | 0 | |a Alison A. Lopez |e verfasserin |4 aut | |
700 | 0 | |a Laura J. Sauvé |e verfasserin |4 aut | |
700 | 0 | |a Bruce A. Vallance |e verfasserin |4 aut | |
700 | 0 | |a Kevan Jacobson |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t International Journal of Infectious Diseases |d Elsevier, 2015 |g 103(2021), Seite 246-256 |w (DE-627)DOAJ000043923 |x 18783511 |7 nnns |
773 | 1 | 8 | |g volume:103 |g year:2021 |g pages:246-256 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.ijid.2020.11.163 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/4289576de7fd4bee8656a08dae821277 |z kostenfrei |
856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S1201971220324759 |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/1201-9712 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_DOAJ | ||
951 | |a AR | ||
952 | |d 103 |j 2021 |h 246-256 |